153 related articles for article (PubMed ID: 23567159)
1. 17β-Estradiol positively modulates growth hormone signaling through the reduction of SOCS2 negative feedback in human osteoblasts.
Bolamperti S; Mrak E; Moro G; Sirtori P; Fraschini G; Guidobono F; Rubinacci A; Villa I
Bone; 2013 Jul; 55(1):84-92. PubMed ID: 23567159
[TBL] [Abstract][Full Text] [Related]
2. The somatotropic axis during the physiological estrus cycle in dairy heifers--Effect on hepatic expression of GHR and SOCS2.
Mense K; Meyerholz M; Gil Araujo M; Lietzau M; Knaack H; Wrenzycki C; Hoedemaker M; Piechotta M
J Dairy Sci; 2015 Apr; 98(4):2409-18. PubMed ID: 25704974
[TBL] [Abstract][Full Text] [Related]
3. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
[TBL] [Abstract][Full Text] [Related]
4. Increased SULT1E1 activity in HepG2 hepatocytes decreases growth hormone stimulation of STAT5b phosphorylation.
Li L; He D; Wilborn TW; Falany JL; Falany CN
Steroids; 2009 Jan; 74(1):20-9. PubMed ID: 18831980
[TBL] [Abstract][Full Text] [Related]
5. Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte.
Yang HL; Sun C; Sun C; Qi RL
Mol Biol Rep; 2012 Sep; 39(9):9113-22. PubMed ID: 22729878
[TBL] [Abstract][Full Text] [Related]
6. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2.
Leung KC; Doyle N; Ballesteros M; Sjogren K; Watts CK; Low TH; Leong GM; Ross RJ; Ho KK
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1016-21. PubMed ID: 12552091
[TBL] [Abstract][Full Text] [Related]
7. GH signaling in human adipose and muscle tissue during 'feast and famine': amplification of exercise stimulation following fasting compared to glucose administration.
Vendelbo MH; Christensen B; Grønbæk SB; Høgild M; Madsen M; Pedersen SB; Jørgensen JO; Jessen N; Møller N
Eur J Endocrinol; 2015 Sep; 173(3):283-90. PubMed ID: 26034073
[TBL] [Abstract][Full Text] [Related]
8. Direct stimulation of bone mass by increased GH signalling in the osteoblasts of Socs2-/- mice.
Dobie R; MacRae VE; Huesa C; van't Hof R; Ahmed SF; Farquharson C
J Endocrinol; 2014 Oct; 223(1):93-106. PubMed ID: 25074853
[TBL] [Abstract][Full Text] [Related]
9. Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and Suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes.
Story DJ; Stephens JM
Obesity (Silver Spring); 2006 Aug; 14(8):1303-11. PubMed ID: 16988072
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
[TBL] [Abstract][Full Text] [Related]
11. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
Leung KC; Brce J; Doyle N; Lee HJ; Leong GM; Sjögren K; Ho KK
Endocrinology; 2007 May; 148(5):2417-23. PubMed ID: 17272397
[TBL] [Abstract][Full Text] [Related]
12. GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells.
Sadowski CL; Wheeler TT; Wang LH; Sadowski HB
Endocrinology; 2001 Sep; 142(9):3890-900. PubMed ID: 11517167
[TBL] [Abstract][Full Text] [Related]
13. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
Goh EL; Zhu T; Leong WY; Lobie PE
Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
[TBL] [Abstract][Full Text] [Related]
14. GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus.
Jørgensen JO; Jessen N; Pedersen SB; Vestergaard E; Gormsen L; Lund SA; Billestrup N
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E899-905. PubMed ID: 16757551
[TBL] [Abstract][Full Text] [Related]
15. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
[TBL] [Abstract][Full Text] [Related]
16. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
Chen Y; Sun D; Krishnamurthy VM; Rabkin R
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
[TBL] [Abstract][Full Text] [Related]
17. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
[TBL] [Abstract][Full Text] [Related]
18. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
[TBL] [Abstract][Full Text] [Related]
19. Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2002 Feb; 143(2):492-503. PubMed ID: 11796503
[TBL] [Abstract][Full Text] [Related]
20. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
